Novo Nordisk joins forces with OpenAI to fast-track drug research
Danish pharma company Novo Nordisk has announced a partnership with OpenAI to apply artificial intelligence across its drug development process.
Original Source
Read the full article at Euronews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.